| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
CRKN Stock Overview
Crown Electrokinetics Corp. develops and sells optical switching films.
Crown ElectroKinetics Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.98 |
| 52 Week High | US$4.85 |
| 52 Week Low | US$0.62 |
| Beta | 0.19 |
| 1 Month Change | -1.62% |
| 3 Month Change | -41.32% |
| 1 Year Change | -79.37% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -87.90% |
Recent News & Updates
Shareholder Returns
| CRKN | US Chemicals | US Market | |
|---|---|---|---|
| 7D | 4.8% | 3.6% | 6.6% |
| 1Y | -79.4% | -8.3% | -18.5% |
Return vs Industry: CRKN underperformed the US Chemicals industry which returned -11.8% over the past year.
Return vs Market: CRKN underperformed the US Market which returned -20.5% over the past year.
Price Volatility
| CRKN volatility | |
|---|---|
| CRKN Average Weekly Movement | 13.2% |
| Chemicals Industry Average Movement | 6.8% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CRKN is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 13% a week.
Volatility Over Time: CRKN's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 30 | Doug Croxall | https://www.crownek.com |
Crown Electrokinetics Corp. develops and sells optical switching films. The company also focuses on commercializing electrokinetic technology for use in the smart glass market. It offers electrokinetic film technology for smart or dynamic glass.
Crown ElectroKinetics Fundamentals Summary
| CRKN fundamental statistics | |
|---|---|
| Market Cap | US$14.29m |
| Earnings (TTM) | -US$5.88m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-2.4x
P/E RatioIs CRKN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CRKN income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$5.88m |
| Earnings | -US$5.88m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.40 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.1% |
How did CRKN perform over the long term?
See historical performance and comparisonValuation
Is CRKN undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
PEG Ratio
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CRKN?
Other financial metrics that can be useful for relative valuation.
| What is CRKN's n/a Ratio? | |
|---|---|
| n/a Ratio | 0x |
| n/a | n/a |
| Market Cap | US$14.29m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | n/a |
| Enterprise Value/EBITDA | -0.7x |
| PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does CRKN's PB Ratio compare to its peers?
| CRKN PB Ratio vs Peers |
|---|
| Company | PB | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 27x |
Price-To-Book vs Peers: CRKN is good value based on its Price-To-Book Ratio (2.5x) compared to the peer average (27x).
Price to Earnings Ratio vs Industry
How does CRKN's PE Ratio compare vs other companies in the U.S. Chemicals Industry?
Price-To-Book vs Industry: CRKN is expensive based on its Price-To-Book Ratio (2.5x) compared to the US Chemicals industry average (2x)
Price to Book Ratio vs Fair Ratio
What is CRKN's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PB Ratio | 2.5x |
| Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate CRKN's Price-To-Book Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of CRKN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate CRKN's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate CRKN's fair value for valuation analysis.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate CRKN's PEG Ratio to determine if it is good value.
Discover undervalued companies
Future Growth
How is Crown ElectroKinetics forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Future Growth Score
5/6Future Growth Score 5/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
87.8%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CRKN is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.9%).
Earnings vs Market: CRKN is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: CRKN is expected to become profitable in the next 3 years.
Revenue vs Market: CRKN's revenue (90.1% per year) is forecast to grow faster than the US market (8.3% per year).
High Growth Revenue: CRKN's revenue (90.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CRKN's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Past Performance
How has Crown ElectroKinetics performed over the past 5 years?
Past Performance Score
0/6Past Performance Score 0/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
-43.3%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CRKN is currently unprofitable.
Growing Profit Margin: CRKN is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: CRKN is unprofitable, and losses have increased over the past 5 years at a rate of 43.3% per year.
Accelerating Growth: Unable to compare CRKN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CRKN is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (30.2%).
Return on Equity
High ROE: CRKN has a negative Return on Equity (-102.74%), as it is currently unprofitable.
Discover strong past performing companies
Financial Health
How is Crown ElectroKinetics's financial position?
Financial Health Score
4/6Financial Health Score 4/6
Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: CRKN's short term assets ($3.3M) exceed its short term liabilities ($935.0K).
Long Term Liabilities: CRKN's short term assets ($3.3M) exceed its long term liabilities ($1.8M).
Debt to Equity History and Analysis
Debt Level: CRKN has more cash than its total debt.
Reducing Debt: CRKN had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CRKN has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: CRKN has less than a year of cash runway if free cash flow continues to reduce at historical rates of 56.4% each year
Discover healthy companies
Dividend
What is Crown ElectroKinetics's current dividend yield, its reliability and sustainability?
Dividend Score
0/6Dividend Score 0/6
Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate CRKN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate CRKN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if CRKN's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CRKN's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as CRKN has not reported any payouts.
Discover strong dividend paying companies
Management
How experienced are the management team and are they aligned to shareholders interests?
1.5yrs
Average board tenure
CEO
Doug Croxall (52 yo)
no data
Tenure
US$1,105,630
Compensation
Mr. Douglas B. Croxall, also known as Doug, is Chairman of the Board and Chief Executive Officer at Crown ElectroKinetics Corp. He serves as Director at Crown ElectroKinetics Corp. since 2015. Prior to co-...
CEO Compensation Analysis
Compensation vs Market: Doug's total compensation ($USD1.11M) is above average for companies of similar size in the US market ($USD758.64K).
Compensation vs Earnings: Doug's compensation has been consistent with company performance over the past year.
Board Members
Experienced Board: CRKN's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Crown ElectroKinetics Corp.'s employee growth, exchange listings and data sources
Key Information
- Name: Crown ElectroKinetics Corp.
- Ticker: CRKN
- Exchange: NasdaqCM
- Founded: 2015
- Industry: Commodity Chemicals
- Sector: Materials
- Implied Market Cap: US$14.293m
- Shares outstanding: 14.58m
- Website: https://www.crownek.com
Number of Employees
Location
- Crown ElectroKinetics Corp.
- 1110 NE Circle Boulevard
- Corvallis
- Oregon
- 97330
- United States
Listings
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/06/24 00:00 |
| End of Day Share Price | 2022/06/24 00:00 |
| Earnings | 2022/03/31 |
| Annual Earnings | 2021/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.